Deregulation of calcium homeostasis mediates secreted α-synuclein-induced neurotoxicity

Neurobiology of Aging

Volumn 34, Issue 12, 2013, Pages 2853-2865

  Melachroinou, Katerina ^a   Xilouri, Maria ^a   Emmanouilidou, Evangelia ^a   Masgrau, Roser ^b   Papazafiri, Panagiota ^c   Stefanis, Leonidas ^a,d   Vekrellis, Kostas ^a  

^a BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^b INSTITUT DE NEUROCIÈNCIES   (Spain)

^c UNIVERSITY OF ATHENS   (Greece)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Alpha synuclein; Calpains; Exosomes; Membrane fluidity; Mitochondria; Neurodegeneration; Parkinson's disease; Secretion

Indexed keywords

ALPHA SYNUCLEIN; CALPAIN; CASPASE 3; VOLTAGE GATED CALCIUM CHANNEL;

ARTICLE; BRAIN CELL; CALCIUM HOMEOSTASIS; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL DIFFERENTIATION; CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EXOSOME; HUMAN; HUMAN CELL; MEMBRANE FLUIDITY; NERVE CELL; NEUROTOXICITY; PARKINSON DISEASE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN SECRETION;

ALPHA-SYNUCLEIN; CALPAINS; EXOSOMES; MEMBRANE FLUIDITY; MITOCHONDRIA; NEURODEGENERATION; PARKINSON'S DISEASE; SECRETION;

ALPHA-SYNUCLEIN; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM SIGNALING; CELLS, CULTURED; CHELATING AGENTS; HOMEOSTASIS; HUMANS; MEMBRANE FLUIDITY; MOLECULAR TARGETED THERAPY; NEURONS; PARKINSON DISEASE;

EID: 84884155816     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.06.006     Document Type: Article

References (45)

1. 2+ channels. Neuroreport 2006, 17:1883-1886.
2. Banoczi Z., Alexa A., Farkas A., Friedrich P., Hudecz F. Novel cell-penetrating calpain substrate. Bioconjug. Chem. 2008, 19:1375-1381.
3. Benner E.J., Mosley R.L., Destache C.J., Lewis T.B., Jackson-Lewis V., Gorantla S., Nemachek C., Green S.R., Przedborski S., Gendelman H.E. Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:9435-9440.
4. Berridge M.J., Bootman M.D., Roderick H.L. Calcium signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 2003, 4:517-529.
5. Cali T., Ottolini D., Negro A., Brini M. α-Synuclein controls mitochondrial calcium homeostasis by enhancing endoplasmic reticulum-mitochondria interactions. J.Biol. Chem. 2012, 287:17914-17929.
6. Camins A., Verdaguer E., Folch J., Pallas M. Involvement of calpain activation in neurodegenerative processes. CNS Drug Rev. 2006, 12:135-148.
7. Chivet M., Hemming F., Pernet-Gallay K., Fraboulet S., Sadoul R. Emerging role of neuronal exosomes in the central nervous system. Front. Physiol. 2012, 3:145.
8. Churchill G.C., Okada Y., Thomas J.M., Genazzani A.A., Patel S., Galione A. NAADP mobilizes Ca(2+) from reserve granules, lysosome-related organelles, in sea urchin eggs. Cell 2002, 111:703-708.
9. Dafnis I., Stratikos E., Tzinia A., Tsilibary E.C., Zannis V.I., Chroni A. An apolipoprotein E4 fragment can promote intracellular accumulation of amyloid peptide beta 42. J.Neurochem. 2010, 115:873-884.
10. Danzer K.M., Haasen D., Karow A.R., Moussaud S., Habeck M., Giese A., Kretzschmar H., Hengerer B., Kostka M. Different species of alpha-synuclein oligomers induce calcium influx and seeding. J.Neurosci. 2007, 27:9220-9232.
11. Danzer K.M., Kranich L.R., Ruf W.P., Cagsal-Getkin O., Winslow A.R., Zhu L., Vanderburg C.R., McLean P.J. Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol. Neurodegener. 2012, 7:42.
12. Dauer W., Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003, 39:889-909.
13. de Brito O.M., Scorrano L. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 2008, 456:605-610.
14. Demuro A., Parker I., Stutzmann G.E. Calcium signaling and amyloid toxicity in Alzheimer disease. J.Biol. Chem. 2010, 285:12463-12468.
15. Emmanouilidou E., Melachroinou K., Roumeliotis T., Garbis S.D., Ntzouni M., Margaritis L.H., Stefanis L., Vekrellis K. Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J.Neurosci. 2010, 30:6838-6851.
16. Farinelli S.E., Greene L.A., Friedman W.J. Neuroprotective actions of dipyridamole on cultured CNS neurons. J.Neurosci. 1998, 18:5112-5123.
17. Furukawa K., Matsuzaki-Kobayashi M., Hasegawa T., Kikuchi A., Sugeno N., Itoyama Y., Wang Y., Yao P.J., Bushlin I., Takeda A. Plasma membrane ion permeability induced by mutant alpha-synuclein contributes to the degeneration of neural cells. J.Neurochem. 2006, 97:1071-1077.
18. Galla H.J., Luisetti J. Lateral and transversal diffusion and phase transitions in erythrocyte membranes. An excimer fluorescence study. Biochim. Biophys. Acta 1980, 596:108-117.
19. Gasser T. Molecular pathogenesis of Parkinson disease: insights from genetic studies. Expert Rev. Mol. Med. 2009, 11:e22.
20. Greer P.L., Greenberg M.E. From synapse to nucleus: calcium-dependent gene transcription in the control of synapse development and function. Neuron 2008, 59:846-860.
21. Hashimoto M., Hossain S., Masumura S. Effect of aging on plasma membrane fluidity of rat aortic endothelial cells. Exp. Gerontol. 1999, 34:687-698.
22. Hettiarachchi N.T., Parker A., Dallas M.L., Pennington K., Hung C.C., Pearson H.A., Boyle J.P., Robinson P., Peers C. α-Synuclein modulation of Ca2+ signaling in human neuroblastoma (SH-SY5Y) cells. J.Neurochem. 2009, 111:1192-1201.
23. Kang S., Cooper G., Dunne S.F., Dusel B., Luan C.H., Surmeier D.J., Silverman R.B. CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease. Nat. Commun. 2012, 3:1146.
24. Kordower J.H., Chu Y., Hauser R.A., Olanow C.W., Freeman T.B. Transplanted dopaminergic neurons develop PD pathologic changes: a second case report. Mov. Disord. 2008, 23:2303-2306.
25. Lamarca V., Scorrano L. When separation means death: killing through the mitochondria, but starting from the endoplasmic reticulum. EMBO J. 2009, 28:1681-1683.
26. Li J.Y., Englund E., Holton J.L., Soulet D., Hagell P., Lees A.J., Lashley T., Quinn N.P., Rehncrona S., Bjorklund A., Widner H., Revesz T., Lindvall O., Brundin P. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat. Med. 2008, 14:501-503.
27. Martin Z.S., Neugebauer V., Dineley K.T., Kayed R., Zhang W., Reese L.C., Taglialatela G. α-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases. J.Neurochem. 2012, 120:440-452.
28. Medeiros R., Kitazawa M., Chabrier M.A., Cheng D., Baglietto-Vargas D., Kling A., Moeller A., Green K.N., LaFerla F.M. Calpain inhibitor A-705253 mitigates Alzheimer's disease-like pathology and cognitive decline in aged 3xTgAD mice. Am. J. Pathol. 2012, 181:616-625.
29. Nalls M.A., Plagnol V., Hernandez D.G., Sharma M., Sheerin U.M., Saad M., Simon-Sanchez J., Schulte C., Lesage S., Sveinbjornsdottir S., Stefansson K., Martinez M., Hardy J., Heutink P., Brice A., Gasser T., Singleton A.B., Wood N.W. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 2011, 377:641-649.
30. Papazafiri P., Bossi M., Meldolesi J. Expression of muscle calsequestrin in epithelial HeLa cells: distribution and functional role. Biochim. Biophys. Acta 1994, 1223:333-340.
31. Patel S., Docampo R. Acidic calcium stores open for business: expanding the potential for intracellular Ca2+ signaling. Trends Cell Biol. 2010, 20:277-286.
32. Schmidt F., Levin J., Kamp F., Kretzschmar H., Giese A., Botzel K. Single-channel electrophysiology reveals a distinct and uniform pore complex formed by alpha-synuclein oligomers in lipid membranes. PloS One 2012, 7:e42545.
33. Smaili S.S., Russell J.T. Permeability transition pore regulates both mitochondrial membrane potential and agonist-evoked Ca2+ signals in oligodendrocyte progenitors. Cell Calcium 1999, 26:121-130.
34. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997, 388:839-840.
35. Stefanis L., Park D.S., Friedman W.J., Greene L.A. Caspase-dependent and -independent death of camptothecin-treated embryonic cortical neurons. J.Neurosci. 1999, 19:6235-6247.
36. Surmeier D.J., Guzman J.N., Sanchez-Padilla J. Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease. Cell Calcium 2010, 47:175-182.
37. Thery C., Amigorena S., Raposo G., Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol. 2006, Chapter 3, Unit 3.22.
38. Tsigelny I.F., Sharikov Y., Wrasidlo W., Gonzalez T., Desplats P.A., Crews L., Spencer B., Masliah E. Role of alpha-synuclein penetration into the membrane in the mechanisms of oligomer pore formation. FEBS J. 2012, 279:1000-1013.
39. Vekrellis K., Stefanis L. Targeting intracellular and extracellular alpha-synuclein as a therapeutic strategy in Parkinson's disease and other synucleinopathies. Expert Opin. Ther. Targets 2012, 16:421-432.
40. Vekrellis K., Xilouri M., Emmanouilidou E., Rideout H.J., Stefanis L. Pathological roles of alpha-synuclein in neurological disorders. Lancet Neurol. 2011, 10:1015-1025.
41. Vekrellis K., Xilouri M., Emmanouilidou E., Stefanis L. Inducible over-expression of wild type alpha-synuclein in human neuronal cells leads to caspase-dependent non-apoptotic death. J.Neurochem. 2009, 109:1348-1362.
42. Vogiatzi T., Xilouri M., Vekrellis K., Stefanis L. Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J.Biol. Chem. 2008, 283:23542-23556.
43. Yamasaki M., Masgrau R., Morgan A.J., Churchill G.C., Patel S., Ashcroft S.J., Galione A. Organelle selection determines agonist-specific Ca2+ signals in pancreatic acinar and beta cells. J.Biol. Chem. 2004, 279:7234-7240.
44. Zhou C., Emadi S., Sierks M.R., Messer A. Ahuman single-chain Fv intrabody blocks aberrant cellular effects of overexpressed alpha-synuclein. Mol. Ther. 2004, 10:1023-1031.
45. Zundorf G., Reiser G. Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection. Antiox. Redox Signal 2011, 14:1275-1288.